PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 17 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $305,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 12,804,000 | $12,636,000 | 21.66% |
| Context Partners Fund, L.P. | 7,175,000 | $7,034,000 | 4.09% |
| Context Capital Management, LLC | 7,175,000 | $7,034,000 | 4.09% |
| Pinnacle Holdings, LLC | 3,260,000 | $3,217,213,000 | 1.11% |
| Venator Capital Management Ltd. | 2,000,000 | $1,960,000 | 0.98% |
| LINDEN ADVISORS LP | 26,617,000 | $26,292,000 | 0.80% |
| WHITEBOX ADVISORS LLC | 21,681,000 | $21,396,000 | 0.65% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $16,518,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,695,000 | $4,657,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $3,124,000 | 0.04% |